5PSQ-071 Real-world results of effectiveness and security of erenumab and galcanezumab in migraine patients
Autor: | A Gracia Moya, C Varon Galcera, I Cardona Pascual, E Florensa Royo, J Vidal Otero, G Vancells Lujan, MQ Gorgas Torner |
---|---|
Rok vydání: | 2022 |
Zdroj: | Section 7: Post Congress additions. |
DOI: | 10.1136/ejhpharm-2022-eahp.421 |
Databáze: | OpenAIRE |
Externí odkaz: |